It isn’t known whether Baqsimi (glucagon) is safe to use while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine whether ...
INDIANAPOLIS, IN and RANCHO CUCAMONGA, CA / ACCESSWIRE / April 24, 2023 / In an effort to continue expanding the availability of BAQSIMI® to patients, Eli Lilly and Company (NYSE: LLY) and Amphastar ...
Each Baqsimi device includes 1 dose of glucagon and cannot be refused. The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of ...
Provides Amphastar with a branded product with growing sales and strong gross margin. Expands Amphastar's international footprint in 26 countries. Builds upon Amphastar's commercial intranasal product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results